Some studies have used many different forms of tumour cells (including necrotic, apoptotic and live cells) and tumour tissue lysates as antigens to load DCs to improve the cytotoxicity of CD8+ T cells.48, 49, 50, 51, 52. This evidence concerns the gene CD8A and neoplasm.